Accelerate Diagnostics Inc (FRA:1A80)
€ 1.74 -0.01 (-0.57%) Market Cap: 40.14 Mil Enterprise Value: 70.40 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Q3 2023 Accelerate Diagnostics Inc Earnings Call Transcript

Nov 09, 2023 / 09:30PM GMT
Release Date Price: €5.4 (+1.89%)
Operator

Good day and welcome to the Accelerate Diagnostics, Inc. 2023 third-quarter results conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Laura Pierson of Accelerate Diagnostics. Please go ahead.

Laura Pierson
Accelerate Diagnostics, Inc. - IR

Before we begin it is important to share that information presented during this call may contain forward-looking statements within the meaning of Section 27-A. of the Securities Act of 1933 and Section 21-E. of the Security Exchange Act of 1934. Forward-looking statements include projections. Statements about our future and those that are not historical facts. All forward-looking statements that are made during this conference call are subject to risks, uncertainties and other factors that could cause our actual results to differ materially. These are discussed in greater detail in our annual report on Form 10-K for the year ended December 31st, 2022, and other reports we file with the SEC.

It is my pleasure to now introduce the company

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot